Economic evaluation of highly purified human menotropin or recombinant follicle-stimulating hormone for controlled ovarian stimulation in high-responder patients: analysis of the Menopur in Gonadotropin-releasing Hormone Antagonist Single Embryo Transfer–High Responder (MEGASET-HR) trial

Economic evaluation of highly purified human menotropin or recombinant follicle-stimulating hormone for controlled ovarian stimulation in high-responder patients: analysis of the Menopur in Gonadotropin-releasing Hormone Antagonist Single Embryo Transfer–High Responder (MEGASET-HR) trial

Objective: To determine the cost of achieving a live birth after first transfer using highly purified human menotropin (HP-hMG) or recombinant follicle-stimulating hormone (FSH) for controlled ovarian stimulation in predicted high-responder patients in the Menopur in Gonadotropin-releasing hormone A...

Full description

Bibliographic Details
Main Authors: Jared C. Robins, M.D., Andrew F. Khair, Ph.D., M.B.A., Eric A. Widra, M.D., Michael M. Alper, M.D., Winnie W. Nelson, Pharm.D., M.S., M.B.A., Eric D. Foster, Ph.D., Anshul Sinha, B.Tech., Masakazu Ando, Ph.D., Patrick W. Heiser, Ph.D., Gaurang S. Daftary, M.D., M.B.A.
Format: Article
Language:English
Published: Elsevier 2020-12-01
Series:F&S Reports
Subjects:
GnRH antagonist
high responders
highly purified menotropin
Menopur
recombinant FSH
Online Access:http://www.sciencedirect.com/science/article/pii/S2666334120300817

Internet

http://www.sciencedirect.com/science/article/pii/S2666334120300817

Similar Items